Fund Name | Location |
Askul | Japan, Koto |
Beijing Hualian Commercial Trade Development | Beijing, Beijing, China |
British Patient Capital | - |
DeltaG Ventures | California, San Jose, United States |
Digital Science | England, London, United Kingdom |
Econocom | France, Ile-de-France, Puteaux |
Futurtech Middle East | - |
Glasscock Financial Services | Kentucky, Louisville, United States |
Green D Ventures | Boston, Massachusetts, United States |
Grouport Ventures | Czech Republic, Prague, Prague |
Humane Entrepreneurship Program | India, Maharashtra, Mumbai |
infinitas capital | Basel, Basel-Stadt, Switzerland |
Jinzhongxing Touzi | China, Hangzhou, Zhejiang |
Kaktus Capital | - |
LongLine Capital | Beijing, Beijing, China |
OceanIQ Capital | California, Redwood Shores, United States |
Octane Capital Management | California, Mountain View, United States |
SEI Ventures | District of Columbia, United States, Washington |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.